444 companies
VCXB
10X Capital Venture Acquisition Corp III - Ordinary Shares
10X Capital Venture Acquisition Corp III (NYSE: VCXB) is a special purpose acquisition company sponsored by 10X Capital, focused on identifying high growth businesses domestically and abroad and bringing them to the public markets.
New York
NYSEAMERICAN
FDMT
4D Molecular Therapeutics Inc
the mission of 4d molecular therapeutics is to design and develop transformative gene therapy products using our proprietary technology to create novel adeno-associated virus variants to be utilized as treatments for serious unmet medical conditions.
California
NASDAQ
AIM
AIM ImmunoTech Inc
aim immunotech inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency disorders in the united states.
Florida
NYSEAMERICAN
AMGN
AMGEN Inc.
Amgen Inc.
California
NASDAQ
ARIA
ARIAD Pharmaceuticals Inc
ARIAD is a global oncology company focused on transforming the lives of cancer patients with breakthrough medicines.
Massachusetts
NASDAQ
ABCZF
Abcam plc
Abcam is a producer, distributor and seller of protein research tools.
United Kingdom
OTC
ABGX
Abgenix Inc
We have entered into a variety of contractual arrangements to use our XenoMouse and XenoMax technologies to generate and/or develop fully human antibodies against numerous antigens or to manufacture fully human antibodies.
California
Inactive
NASDAQ
ABLYF
Ablynx NV
Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand.
Belgium
Inactive
NASDAQ
ACEL
Accel Entertainment Inc.
New Jersey
Inactive
NYSE
XLRN
Acceleron Pharma Inc
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases.
Massachusetts
NASDAQ
ACGN
Aceragen Inc
idera pharmaceuticals is a clinical stage biotechnology company with expertise in discovering, developing and commercializing novel nucleic acid therapeutics to treat patients with serious and life-threatening diseases.
Pennsylvania
NASDAQ
ACHL
Achilles Therapeutics Plc
achilles therapeutics’ mission is to develop next-generation, patient-specific therapies that harness the immune system to destroy cancer cells.
United Kingdom
NASDAQ
ACORQ
Acorda Therapeutics Inc
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders.
New York
NASDAQ
ABOS
Acumen Pharmaceuticals Inc
acumen is forging a new path towards safe and effective treatments for alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic amyloid-beta oligomers.
Virginia
NASDAQ
ADAP
Adaptimmune Therapeutics Plc
adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer.
United Kingdom
NASDAQ
ADPT
Adaptive Biotechnologies Corp
we are a commercial-stage, biotechnology organization located in the hot biotech locations of seattle, washington and south san francisco, ca.
Washington
NASDAQ
ADMA
Adma Biologics Inc
adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases.
New Jersey
NASDAQ
ADLS
Advanced Life Sciences Holdings, Inc.
Advanced Life Sciences Holdings, Inc.
Inactive
OTC
APTCF
Advanced Proteome Therapeutics Corporation
Advanced Proteome Therapeutics Corp.
Massachusetts
OTC
ATISZ
Advanced Tissue Sciences Inc
California
Inactive
NASDAQ